Synaptics (SYNA) Financials

$132.33 +2.51 (+1.93%)

Closing price 04:00 PM Eastern

Extended Trading

$130.62 -1.71 (-1.29%)

As of 04:32 PM Eastern

Annual Income Statements for Synaptics

This table shows Synaptics' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/27/2015	6/25/2016	6/24/2017	6/30/2018	6/29/2019	6/27/2020	6/26/2021	6/25/2022	6/24/2023	6/29/2024	6/28/2025
Net Income / (Loss) Attributable to Common Shareholders	110	72	49	-124	-23	119	80	258	74	126	-48
Consolidated Net Income / (Loss)	110	72	49	-124	-23	119	80	258	74	126	-48
Net Income / (Loss) Continuing Operations	110	72	49	-124	-23	119	80	258	74	126	-48
Total Pre-Tax Income	160	76	61	-82	-21	159	120	321	126	-125	-114
Total Operating Income	162	75	65	-62	-6.30	69	147	350	154	-102	-94
Total Gross Profit	579	582	524	480	497	543	611	943	716	440	480
Total Revenue	1,703	1,667	1,718	1,630	1,472	1,334	1,340	1,740	1,355	959	1,074
Operating Revenue	1,703	1,667	1,718	1,630	1,472	1,334	1,340	1,740	1,355	959	1,074
Total Cost of Revenue	1,124	1,085	1,195	1,150	975	791	728	797	639	520	594
Operating Cost of Revenue	1,124	1,085	1,195	1,150	975	791	728	797	639	520	594
Total Operating Expenses	417	506	459	542	503	474	464	593	562	541	575
Selling, General & Admin Expense	128	162	138	154	131	127	145	168	175	161	180
Research & Development Expense	293	311	292	363	343	303	313	367	351	336	347
Amortization Expense	14	19	12	13	12	12	33	39	35	17	17
Impairment Charge	0.00	6.70	-	-	-	-	-	-	0.00	16	14
Restructuring Charge	0.00	8.60	7.30	12	18	33	7.40	18	0.00	11	17
Total Other Income / (Expense), net	-2.00	0.40	-3.40	-20	-15	91	-27	-30	-28	-23	-19
Interest Expense	3.80	4.80	6.00	22	21	23	30	38	56	65	46
Interest & Investment Income	1.80	2.10	1.90	2.30	6.70	7.90	2.90	3.00	27	42	27
Income Tax Expense	50	3.40	12	41	0.30	39	31	65	52	-250	-66
Basic Earnings per Share	$2.99	$1.97	$1.40	($3.63)	($0.66)	$3.54	$2.29	$6.60	$1.86	$3.20	($1.22)
Weighted Average Basic Shares Outstanding	36.90M	36.60M	34.80M	34.20M	34.60M	33.60M	34.80M	39M	39.60M	39.20M	39.30M
Diluted Earnings per Share	$2.84	$1.91	$1.37	($3.63)	($0.66)	$3.41	$2.08	$6.33	$1.83	$3.16	($1.22)
Weighted Average Diluted Shares Outstanding	38.90M	37.90M	35.60M	34.20M	34.60M	34.80M	38.30M	40.70M	40.20M	39.70M	39.30M
Weighted Average Basic & Diluted Shares Outstanding	36.90M	36.60M	34.90M	34.20M	32.91M	34.23M	38.85M	39.63M	38.58M	39.58M	38.66M

This table shows Synaptics' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	12/27/2025	3/28/2026
Net Income / (Loss) Attributable to Common Shareholders	-56	-9.00	-18	208	-23	1.80	-22	-4.70	-21	-15	-8.00
Consolidated Net Income / (Loss)	-56	-9.00	-18	208	-23	1.80	-22	-4.70	-21	-15	-8.00
Net Income / (Loss) Continuing Operations	-56	-9.00	-18	208	-23	1.80	-22	-4.70	-21	-15	-8.00
Total Pre-Tax Income	-41	-24	-23	-37	-34	-26	-27	-26	-23	-18	-15
Total Operating Income	-35	-18	-17	-31	-28	-15	-26	-24	-23	-15	-13
Total Gross Profit	107	109	110	113	121	122	116	122	125	132	133
Total Revenue	238	237	237	247	258	267	267	283	293	303	294
Operating Revenue	238	237	237	247	258	267	267	283	293	303	294
Total Cost of Revenue	131	128	127	134	137	145	151	161	168	171	161
Operating Cost of Revenue	131	128	127	134	137	145	151	161	168	171	161
Total Operating Expenses	142	127	128	145	149	137	142	146	148	147	146
Selling, General & Admin Expense	42	40	41	39	50	50	35	46	46	48	50
Research & Development Expense	87	82	83	84	81	83	89	94	94	95	95
Amortization Expense	5.50	3.90	4.00	3.90	3.80	3.80	4.50	4.60	4.70	3.80	1.90
Impairment Charge	-	-	0.00	-	-	-	14	-	-	-	0.00
Restructuring Charge	8.00	1.30	-0.20	1.40	14	0.80	0.50	1.40	2.50	0.10	0.00
Total Other Income / (Expense), net	-5.40	-6.10	-5.90	-5.60	-5.90	-11	-1.10	-1.60	0.50	-2.40	-2.50
Interest Expense	5.40	6.10	5.90	-	-	6.50	0.00	29	-	0.00	0.00
Interest & Investment Income	-	-	-	-	-5.90	-4.30	-1.10	-	0.50	-2.40	-2.50
Income Tax Expense	15	-15	-5.20	-245	-11	-28	-5.60	-21	-2.10	-2.70	-7.20
Basic Earnings per Share	($1.43)	($0.23)	($0.46)	$5.32	($0.58)	$0.05	($0.56)	($0.13)	($0.53)	($0.38)	($0.21)
Weighted Average Basic Shares Outstanding	38.80M	39.20M	39.30M	39.20M	39.80M	39.70M	39M	39.30M	38.80M	38.90M	38.80M
Diluted Earnings per Share	($1.43)	($0.23)	($0.46)	$5.28	($0.58)	$0.05	($0.56)	($0.13)	($0.53)	($0.38)	($0.21)
Weighted Average Diluted Shares Outstanding	38.80M	39.20M	39.30M	39.70M	39.80M	39.80M	39M	39.30M	38.80M	38.90M	38.80M
Weighted Average Basic & Diluted Shares Outstanding	39.20M	39.30M	39.50M	39.58M	40.06M	39.19M	38.55M	38.66M	38.99M	38.73M	38.64M

This table details how cash moves in and out of Synaptics' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/27/2015	6/25/2016	6/24/2017	6/30/2018	6/29/2019	6/27/2020	6/26/2021	6/25/2022	6/24/2023	6/29/2024	6/28/2025
Net Change in Cash & Equivalents	-47	-48	16	-67	27	436	73	-12	101	-48	-485
Net Cash From Operating Activities	204	257	153	145	154	222	319	463	332	136	142
Net Cash From Continuing Operating Activities	204	257	153	145	154	222	319	463	332	136	142
Net Income / (Loss) Continuing Operations	110	72	49	-124	-23	119	80	258	74	126	-48
Consolidated Net Income / (Loss)	110	72	49	-124	-23	119	80	258	74	126	-48
Depreciation Expense	25	31	33	39	36	27	22	24	27	28	29
Amortization Expense	88	74	61	102	93	70	148	124	130	82	114
Non-Cash Adjustments To Reconcile Net Income	35	71	60	73	56	-49	48	106	149	160	151
Changes in Operating Assets and Liabilities, net	-55	8.40	-49	55	-7.20	55	22	-49	-49	-259	-105
Net Cash From Investing Activities	-341	-27	-42	-439	-21	120	-523	-483	-6.00	-158	-298
Net Cash From Continuing Investing Activities	-341	-27	-42	-439	-21	120	-523	-483	-6.00	-158	-298
Purchase of Property, Plant & Equipment	-52	-29	-31	-34	-24	-16	-21	-31	-34	-34	-26
Acquisitions	-294	-4.60	-18	-404	0.00	-2.50	-627	-501	-16	-14	-211
Purchase of Investments	0.00	0.00	-17	-	0.00	0.00	-5.00	-36	0.00	-137	-61
Sale and/or Maturity of Investments	4.90	6.60	7.50	0.00	2.80	0.00	96	24	44	27	0.00
Other Investing Activities, net	0.00	0.00	17	-	-	0.00	34	-	0.10	0.00	0.00
Net Cash From Financing Activities	94	-281	-94	227	-107	94	274	14	-221	-25	-331
Net Cash From Continuing Financing Activities	94	-281	-94	227	-107	94	274	14	-221	-25	-331
Repayment of Debt	-4.20	-7.90	-20	-221	0.00	-0.70	-106	-11	-0.90	-4.10	-587
Repurchase of Common Equity	-121	-241	-88	-94	-119	-30	0.00	0.00	-184	0.00	-128
Issuance of Debt	245	0.00	0.00	515	0.00	100	400	600	0.00	0.00	440
Issuance of Common Equity	49	32	25	32	21	35	28	15	18	16	14
Other Financing Activities, net	-3.20	-4.10	-5.50	-5.40	-9.40	-9.70	-48	-590	-55	-37	-70
Effect of Exchange Rate Changes	-3.70	3.40	-0.90	0.00	0.10	0.00	2.20	-6.60	-3.50	-0.90	1.90
Cash Interest Paid	3.10	5.00	6.00	3.80	3.60	3.70	9.60	25	52	63	39
Cash Income Taxes Paid	86	47	22	26	16	19	0.00	-	91	55	47

This table details how cash moves in and out of Synaptics' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	12/27/2025	3/28/2026
Net Change in Cash & Equivalents	-123	45	-18	49	-23	-258	-236	31	68	-23	-33
Net Cash From Operating Activities	45	39	-14	65	-11	23	73	57	30	30	22
Net Cash From Continuing Operating Activities	45	39	-14	65	-11	23	73	57	30	30	22
Net Income / (Loss) Continuing Operations	-56	-9.00	-18	208	-23	1.80	-22	-4.70	-21	-15	-8.00
Consolidated Net Income / (Loss)	-56	-9.00	-18	208	-23	1.80	-22	-4.70	-21	-15	-8.00
Depreciation Expense	7.20	6.80	6.80	6.80	7.20	7.40	7.20	7.10	7.50	7.60	7.90
Amortization Expense	23	18	18	22	25	25	31	34	35	34	26
Non-Cash Adjustments To Reconcile Net Income	46	34	34	46	31	44	38	39	39	42	43
Changes in Operating Assets and Liabilities, net	25	-11	-55	-218	-51	-55	19	-18	-31	-39	-47
Net Cash From Investing Activities	-150	10	-6.90	-11	-9.10	-5.50	-274	-8.90	49	-12	-12
Net Cash From Continuing Investing Activities	-150	10	-6.90	-11	-9.10	-5.50	-274	-8.90	49	-12	-12
Purchase of Property, Plant & Equipment	-6.70	-10	-9.00	-7.70	-9.10	-4.70	-5.40	-6.60	-12	-12	-12
Net Cash From Financing Activities	-18	-5.80	3.50	-4.70	-3.50	-275	-35	-18	-10	-41	-43
Net Cash From Continuing Financing Activities	-18	-5.80	3.50	-4.70	-3.50	-275	-35	-18	-10	-41	-43
Repurchase of Common Equity	-	-	-	-	0.00	-	-38	-16	-7.20	-36	-39
Other Financing Activities, net	-25	-4.30	-4.10	-3.20	-11	-53	-2.90	-2.40	-11	-4.30	-3.80
Effect of Exchange Rate Changes	-0.60	1.10	-0.90	-0.50	0.70	-0.10	0.10	1.20	-0.20	-	-0.10

This table presents Synaptics' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/27/2015	6/25/2016	6/24/2017	6/30/2018	6/29/2019	6/27/2020	6/26/2021	6/25/2022	6/24/2023	6/29/2024	6/28/2025
Total Assets	1,519	1,300	1,267	1,500	1,410	1,694	2,227	2,858	2,611	2,825	2,584
Total Current Assets	916	780	792	740	731	1,078	1,180	1,403	1,272	1,162	752
Cash & Equivalents	400	352	368	301	328	763	836	824	925	877	392
Short-Term Investments	-	-	-	-	-	-	0.00	52	9.60	0.00	61
Accounts Receivable	325	253	255	289	230	195	228	322	164	142	130
Inventories, net	140	146	131	131	159	102	82	170	137	114	140
Prepaid Expenses	51	29	38	18	15	17	33	36	37	29	30
Plant, Property, & Equipment, net	123	113	114	118	103	84	91	63	66	76	72
Total Noncurrent Assets	480	407	361	643	576	532	956	1,392	1,273	1,587	1,760
Goodwill	207	207	207	373	373	361	570	807	816	816	872
Intangible Assets	235	160	101	219	145	93	302	390	299	288	262
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	-	-	-	68	346	409
Other Noncurrent Operating Assets	38	40	53	51	58	78	84	195	90	137	217
Total Liabilities & Shareholders' Equity	1,519	1,300	1,267	1,500	1,410	1,694	2,227	2,858	0.00	2,825	2,584
Total Liabilities	726	595	527	771	753	875	1,260	1,592	1,368	1,358	1,190
Total Current Liabilities	447	351	310	284	254	244	787	463	260	277	271
Accounts Payable	189	173	136	157	98	61	98	142	46	88	99
Accrued Expenses	74	82	102	80	106	91	96	145	99	184	172
Total Noncurrent Liabilities	280	244	216	487	499	631	473	1,128	1,108	1,081	919
Long-Term Debt	231	217	202	451	468	587	394	976	972	967	835
Other Noncurrent Operating Liabilities	15	19	14	36	30	44	79	153	136	114	84
Total Equity & Noncontrolling Interests	793	705	740	729	657	819	967	1,266	1,243	1,467	1,395
Total Preferred & Common Equity	793	705	740	729	657	819	967	1,266	1,243	1,467	1,395
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00
Total Common Equity	793	705	740	729	657	819	967	1,266	1,243	1,467	1,395
Common Stock	844	929	1,005	1,195	1,266	1,340	1,392	924	1,009	1,107	1,212
Retained Earnings	593	665	714	606	584	701	781	1,039	1,112	1,238	1,190
Treasury Stock	-652	-892	-980	-1,074	-1,192	-1,223	-1,205	-695	-878	-878	-1,007

This table presents Synaptics' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/24/2022	3/25/2023	9/30/2023	12/30/2023	3/30/2024	9/28/2024	12/28/2024	3/29/2025	9/27/2025	12/27/2025	3/28/2026
Total Assets	2,725	2,715	2,549	2,573	2,540	2,791	2,528	2,554	2,577	2,563	2,522
Total Current Assets	1,324	1,334	1,109	1,147	1,123	1,140	891	713	749	771	755
Cash & Equivalents	819	898	801	846	828	854	596	360	460	437	404
Short-Term Investments	40	36	23	2.60	0.50	-	-	61	0.00	0.00	0.00
Accounts Receivable	255	218	111	127	145	136	147	132	120	133	163
Inventories, net	178	148	132	125	114	120	120	133	143	158	161
Prepaid Expenses	33	34	41	47	35	31	28	26	27	43	27
Plant, Property, & Equipment, net	66	69	67	71	74	80	75	71	77	83	83
Total Noncurrent Assets	1,335	1,311	1,373	1,355	1,343	1,572	1,562	1,771	1,751	1,709	1,685
Goodwill	816	816	816	816	816	816	820	872	872	872	872
Intangible Assets	334	331	289	270	252	264	242	296	270	236	210
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	358	369	389	413	418	424
Other Noncurrent Operating Assets	185	164	268	268	275	133	131	213	196	183	179
Total Liabilities & Shareholders' Equity	2,725	2,715	2,549	2,573	2,540	2,791	2,528	2,554	2,577	2,563	2,522
Total Liabilities	1,425	1,394	1,344	1,353	1,304	1,324	1,151	1,167	1,177	1,180	1,164
Total Current Liabilities	299	269	246	253	211	254	230	248	262	263	248
Accounts Payable	83	61	64	83	71	83	84	90	93	96	78
Accrued Expenses	113	94	103	104	99	136	115	111	170	168	171
Total Noncurrent Liabilities	1,126	1,125	1,099	1,100	1,093	1,070	922	920	915	916	916
Long-Term Debt	974	973	970	969	968	966	833	834	835	836	837
Other Noncurrent Operating Liabilities	152	152	129	131	126	104	89	86	79	80	79
Total Equity & Noncontrolling Interests	1,300	1,321	1,204	1,220	1,235	1,467	1,376	1,387	1,401	1,384	1,359
Total Preferred & Common Equity	1,300	1,321	1,204	1,220	1,235	1,467	1,376	1,387	1,401	1,384	1,359
Preferred Stock	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,300	1,321	1,204	1,220	1,235	1,467	1,376	1,387	1,401	1,384	1,359
Common Stock	946	981	1,026	1,051	1,084	1,131	1,112	1,183	1,245	1,280	1,302
Retained Earnings	1,125	1,136	1,057	1,048	1,029	1,215	1,216	1,195	1,169	1,155	1,147
Treasury Stock	-769	-795	-878	-878	-878	-878	-953	-991	-1,014	-1,051	-1,090

This table displays calculated financial ratios and metrics derived from Synaptics' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/27/2015	6/25/2016	6/24/2017	6/30/2018	6/29/2019	6/27/2020	6/26/2021	6/25/2022	6/24/2023	6/29/2024	6/28/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	79.74%	-2.12%	3.08%	-5.12%	-9.70%	-9.39%	0.43%	29.87%	-22.11%	-29.20%	11.98%
EBITDA Growth	192.67%	-33.37%	-13.30%	-50.09%	53.40%	122.50%	16.72%	59.12%	-37.99%	-97.56%	544.74%
EBIT Growth	123.72%	-51.73%	-16.48%	-194.65%	89.82%	2,861.90%	-15.52%	142.04%	-56.63%	-165.85%	7.38%
NOPAT Growth	145.96%	-35.75%	-27.84%	-183.61%	89.82%	1,284.02%	107.92%	157.70%	-67.78%	-178.91%	7.38%
Net Income Growth	136.40%	-34.60%	-32.41%	-354.30%	81.55%	618.78%	-33.00%	223.49%	-71.42%	70.65%	-138.06%
EPS Growth	125.40%	-32.75%	-28.27%	-364.96%	81.82%	616.67%	-39.00%	204.33%	-71.09%	72.68%	-138.61%
Operating Cash Flow Growth	55.09%	25.72%	-40.41%	-5.17%	6.34%	43.84%	43.91%	44.96%	-28.36%	-59.00%	4.49%
Free Cash Flow Firm Growth	-376.16%	144.15%	-57.42%	-756.36%	123.06%	170.50%	8.59%	-351.38%	130.89%	-298.03%	19.19%
Invested Capital Growth	150.24%	-7.44%	0.19%	49.13%	-9.24%	-19.49%	-18.22%	161.20%	-6.19%	21.42%	13.72%
Revenue Q/Q Growth	10.66%	-8.51%	6.35%	-2.28%	-5.97%	-1.30%	3.89%	9.34%	-15.53%	2.14%	3.41%
EBITDA Q/Q Growth	9.91%	-26.78%	32.25%	0.00%	-22.32%	104.99%	-8.77%	10.01%	-30.69%	-38.71%	66.10%
EBIT Q/Q Growth	2.94%	-45.70%	174.79%	-28.69%	-127.16%	601.61%	-28.22%	26.17%	-50.66%	6.36%	6.83%
NOPAT Q/Q Growth	-1.91%	-35.83%	110.84%	-75.85%	-103.38%	249.24%	25.03%	24.83%	-54.79%	6.36%	6.83%
Net Income Q/Q Growth	-2.80%	-34.72%	104.18%	-18.42%	-205.05%	782.76%	-47.49%	33.70%	-59.09%	218.38%	-128.93%
EPS Q/Q Growth	-3.73%	-33.68%	98.55%	-16.72%	-203.13%	810.42%	-50.48%	33.54%	-58.78%	217.47%	-129.12%
Operating Cash Flow Q/Q Growth	-4.18%	46.63%	-29.77%	-21.83%	29.91%	4.77%	19.19%	11.95%	-15.28%	-17.84%	-5.21%
Free Cash Flow Firm Q/Q Growth	3.35%	27.14%	-19.84%	-13.85%	-37.37%	64.18%	180.66%	-532.96%	-19.91%	-283.86%	42.80%
Invested Capital Q/Q Growth	3.91%	-6.60%	-0.30%	2.33%	-7.95%	-8.92%	-50.98%	-0.96%	-5.78%	13.21%	-1.26%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	33.98%	34.89%	30.47%	29.45%	33.77%	40.72%	45.63%	54.21%	52.83%	45.84%	44.72%
EBITDA Margin	16.17%	11.01%	9.26%	4.87%	8.27%	20.32%	23.61%	28.93%	23.03%	0.79%	4.56%
Operating Margin	9.52%	4.51%	3.77%	-3.80%	-0.43%	5.17%	10.97%	20.14%	11.39%	-10.59%	-8.76%
EBIT Margin	9.52%	4.70%	3.81%	-3.80%	-0.43%	13.04%	10.97%	20.45%	11.39%	-10.59%	-8.76%
Profit (Net Income) Margin	6.48%	4.33%	2.84%	-7.61%	-1.56%	8.91%	5.94%	14.80%	5.43%	13.09%	-4.45%
Tax Burden Percent	68.91%	95.50%	79.61%	151.71%	110.10%	74.53%	66.28%	80.34%	58.41%	-100.80%	42.11%
Interest Burden Percent	98.77%	96.55%	93.73%	132.15%	330.16%	91.61%	81.70%	90.08%	81.66%	122.64%	120.62%
Effective Tax Rate	31.09%	4.50%	19.90%	0.00%	0.00%	24.22%	26.14%	20.16%	41.59%	0.00%	0.00%
Return on Invested Capital (ROIC)	25.13%	11.74%	8.80%	-5.90%	-0.53%	7.25%	18.60%	29.49%	6.78%	-4.99%	-3.94%
ROIC Less NNEP Spread (ROIC-NNEP)	25.59%	11.46%	11.06%	14,679.55%	-13.27%	-359.61%	27.96%	42.74%	-15.35%	276.64%	3.61%
Return on Net Nonoperating Assets (RNNOA)	-10.35%	-2.10%	-2.05%	-10.99%	-2.78%	8.84%	-9.68%	-6.43%	-0.91%	14.26%	0.60%
Return on Equity (ROE)	14.78%	9.64%	6.75%	-16.89%	-3.30%	16.09%	8.91%	23.06%	5.87%	9.27%	-3.34%
Cash Return on Invested Capital (CROIC)	-60.66%	19.47%	8.61%	-45.35%	9.16%	28.85%	38.64%	-59.77%	13.17%	-24.34%	-16.78%
Operating Return on Assets (OROA)	12.77%	5.55%	5.10%	-4.48%	-0.43%	11.21%	7.50%	13.99%	5.64%	-3.74%	-3.48%
Return on Assets (ROA)	8.69%	5.12%	3.80%	-8.97%	-1.57%	7.66%	4.06%	10.13%	2.69%	4.62%	-1.77%
Return on Common Equity (ROCE)	14.78%	9.64%	6.75%	-16.89%	-3.30%	16.09%	8.91%	23.06%	5.87%	9.27%	-3.34%
Return on Equity Simple (ROE_SIMPLE)	13.92%	10.24%	6.59%	-17.02%	-3.48%	14.50%	8.23%	20.33%	5.92%	8.56%	0.00%
Net Operating Profit after Tax (NOPAT)	112	72	52	-43	-4.41	52	109	280	90	-71	-66
NOPAT Margin	6.56%	4.31%	3.02%	-2.66%	-0.30%	3.91%	8.10%	16.08%	6.65%	-7.41%	-6.13%
Net Nonoperating Expense Percent (NNEP)	-0.46%	0.28%	-2.26%	-14,685.45%	12.74%	366.86%	-9.36%	-13.25%	22.13%	-281.63%	-7.56%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-	-2.95%
Cost of Revenue to Revenue	66.02%	65.11%	69.53%	70.55%	66.23%	59.28%	54.37%	45.79%	47.17%	54.16%	55.28%
SG&A Expenses to Revenue	7.51%	9.70%	8.01%	9.45%	8.92%	9.52%	10.82%	9.68%	12.91%	16.81%	16.78%
R&D to Revenue	17.22%	18.67%	17.01%	22.28%	23.28%	22.68%	23.40%	21.11%	25.92%	35.05%	32.28%
Operating Expenses to Revenue	24.46%	30.37%	26.71%	33.25%	34.19%	35.55%	34.65%	34.07%	41.44%	56.43%	53.48%
Earnings before Interest and Taxes (EBIT)	162	78	65	-62	-6.30	174	147	356	154	-102	-94
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	275	184	159	79	122	271	316	503	312	7.60	49
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.01	2.73	2.78	2.39	1.53	2.34	5.37	4.03	2.58	2.38	1.79
Price to Tangible Book Value (P/TBV)	9.06	5.69	4.76	12.70	7.20	5.25	54.29	73.07	24.96	9.62	9.59
Price to Revenue (P/Rev)	1.87	1.15	1.20	1.07	0.68	1.44	3.88	2.93	2.37	3.63	2.32
Price to Earnings (P/E)	28.80	26.65	42.17	0.00	0.00	16.12	65.27	19.81	43.58	27.74	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.47%	3.75%	2.37%	0.00%	0.00%	6.20%	1.53%	5.05%	2.29%	3.61%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.75	3.07	3.24	2.15	1.44	2.71	9.05	3.79	2.53	2.29	1.62
Enterprise Value to Revenue (EV/Rev)	1.77	1.08	1.11	1.16	0.78	1.30	3.55	2.99	2.40	3.73	2.68
Enterprise Value to EBITDA (EV/EBITDA)	10.97	9.85	11.99	23.84	9.41	6.41	15.03	10.34	10.42	471.01	58.76
Enterprise Value to EBIT (EV/EBIT)	18.63	23.08	29.16	0.00	0.00	9.99	32.33	14.63	21.07	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	27.03	25.16	36.80	0.00	0.00	33.29	43.78	18.61	36.07	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	14.81	7.04	12.47	13.06	7.43	7.84	14.89	11.25	9.81	26.34	20.28
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	15.17	37.60	0.00	14.92	8.37	21.07	0.00	18.57	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.31	0.33	0.29	0.62	0.71	0.72	0.41	0.78	0.79	0.66	0.60
Long-Term Debt to Equity	0.29	0.31	0.27	0.62	0.71	0.72	0.41	0.77	0.78	0.66	0.60
Financial Leverage	-0.40	-0.18	-0.19	0.00	0.21	-0.02	-0.35	-0.15	0.06	0.05	0.17
Leverage Ratio	1.70	1.88	1.78	1.88	2.10	2.10	2.19	2.28	2.18	2.01	1.89
Compound Leverage Factor	1.68	1.82	1.66	2.49	6.93	1.93	1.79	2.05	1.78	2.46	2.28
Debt to Total Capital	23.41%	25.04%	22.67%	38.19%	41.60%	41.73%	28.97%	43.67%	44.03%	39.88%	37.44%
Short-Term Debt to Total Capital	1.09%	2.00%	1.57%	0.00%	0.00%	0.00%	0.00%	0.27%	0.27%	0.25%	0.00%
Long-Term Debt to Total Capital	22.32%	23.04%	21.10%	38.19%	41.60%	41.73%	28.97%	43.40%	43.76%	39.63%	37.44%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	76.59%	74.96%	77.33%	61.81%	58.40%	58.27%	71.03%	56.33%	55.97%	60.12%	62.56%
Debt to EBITDA	0.88	1.28	1.36	5.68	3.84	2.16	1.25	1.95	3.13	128.01	17.04
Net Debt to EBITDA	-0.57	-0.64	-0.95	1.89	1.15	-0.65	-1.40	0.21	0.14	12.63	7.80
Long-Term Debt to EBITDA	0.84	1.18	1.27	5.68	3.84	2.16	1.25	1.94	3.11	127.22	17.04
Debt to NOPAT	2.17	3.28	4.19	-10.40	-106.19	11.23	3.63	3.51	10.85	-13.68	-12.67
Net Debt to NOPAT	-1.41	-1.62	-2.91	-3.45	-31.86	-3.39	-4.07	0.38	0.48	-1.35	-5.80
Long-Term Debt to NOPAT	2.07	3.02	3.90	-10.40	-106.19	11.23	3.63	3.49	10.78	-13.60	-12.67
Altman Z-Score	5.02	4.53	5.12	3.24	2.82	3.61	4.00	3.85	3.18	2.75	2.42
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.05	2.22	2.55	2.61	2.88	4.41	1.50	3.03	4.89	4.19	2.78
Quick Ratio	1.62	1.72	2.01	2.08	2.20	3.93	1.35	2.59	4.22	3.68	2.15
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-270	119	51	-333	77	208	226	-567	175	-347	-280
Operating Cash Flow to CapEx	393.26%	897.20%	486.94%	425.22%	650.63%	0.00%	1,512.80%	0.00%	972.14%	402.07%	550.39%
Free Cash Flow to Firm to Interest Expense	-71.01	24.82	8.45	-15.00	3.62	9.23	7.57	-14.80	3.16	-5.31	-6.05
Operating Cash Flow to Interest Expense	53.71	53.46	25.48	6.53	7.27	9.86	10.71	12.08	5.97	2.08	3.07
Operating Cash Flow Less CapEx to Interest Expense	40.05	47.50	20.25	5.00	6.16	15.30	10.00	12.73	5.36	1.56	2.51
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.34	1.18	1.34	1.18	1.01	0.86	0.68	0.68	0.50	0.35	0.40
Accounts Receivable Turnover	6.55	5.78	6.77	5.99	5.67	6.27	6.32	6.32	5.58	6.26	7.88
Inventory Turnover	10.11	7.57	8.60	8.76	6.73	6.07	7.92	6.33	4.17	4.14	4.69
Fixed Asset Turnover	16.68	14.12	15.17	14.08	13.34	14.24	15.27	22.58	20.96	13.52	14.56
Accounts Payable Turnover	7.87	6.01	7.74	7.86	7.64	9.95	9.21	6.66	6.81	7.80	6.39
Days Sales Outstanding (DSO)	55.69	63.19	53.94	60.93	64.35	58.19	57.71	57.74	65.45	58.27	46.33
Days Inventory Outstanding (DIO)	36.12	48.19	42.44	41.67	54.26	60.16	46.10	57.66	87.62	88.23	77.90
Days Payable Outstanding (DPO)	46.36	60.75	47.15	46.44	47.76	36.67	39.64	54.85	53.56	46.82	57.16
Cash Conversion Cycle (CCC)	45.45	50.63	49.23	56.15	70.84	81.68	64.17	60.56	99.51	99.68	67.07
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	636	588	589	879	798	642	525	1,372	1,287	1,563	1,777
Invested Capital Turnover	3.83	2.72	2.92	2.22	1.76	1.85	2.29	1.83	1.02	0.67	0.64
Increase / (Decrease) in Invested Capital	382	-47	1.10	290	-81	-156	-117	847	-85	276	214
Enterprise Value (EV)	3,022	1,807	1,907	1,893	1,146	1,738	4,753	5,206	3,251	3,580	2,879
Market Capitalization	3,179	1,924	2,058	1,744	1,005	1,915	5,195	5,101	3,208	3,484	2,497
Book Value per Share	$21.53	$19.14	$21.58	$21.07	$19.05	$24.07	$27.48	$31.97	$31.46	$37.14	$36.19
Tangible Book Value per Share	$9.53	$9.17	$12.60	$3.97	$4.05	$10.72	$2.72	$1.76	$3.25	$9.17	$6.76
Total Capital	1,036	941	957	1,180	1,126	1,406	1,362	2,248	2,221	2,440	2,230
Total Debt	242	236	217	451	468	587	394	982	978	973	835
Total Long-Term Debt	231	217	202	451	468	587	394	976	972	967	835
Net Debt	-158	-117	-151	150	141	-177	-442	106	44	96	382
Capital Expenditures (CapEx)	52	29	31	34	24	-122	21	-25	34	34	26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	81	96	129	155	149	70	-443	70	84	14	29
Debt-free Net Working Capital (DFNWC)	481	448	497	456	477	834	393	946	1,018	891	481
Net Working Capital (NWC)	469	429	482	456	477	834	393	940	1,012	885	481
Net Nonoperating Expense (NNE)	1.38	-0.38	3.02	81	18	-67	29	22	17	-197	-18
Net Nonoperating Obligations (NNO)	-158	-117	-151	150	141	-177	-442	106	44	96	382
Total Depreciation and Amortization (D&A)	113	105	94	141	128	97	169	148	158	109	143
Debt-free, Cash-free Net Working Capital to Revenue	4.74%	5.75%	7.50%	9.49%	10.15%	5.26%	-33.09%	4.02%	6.17%	1.48%	2.65%
Debt-free Net Working Capital to Revenue	28.22%	26.88%	28.90%	27.95%	32.41%	62.49%	29.34%	54.38%	75.12%	92.88%	44.77%
Net Working Capital to Revenue	27.56%	25.75%	28.03%	27.95%	32.41%	62.49%	29.34%	54.03%	74.67%	92.26%	44.77%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.99	$1.97	$1.40	($3.63)	($0.66)	$3.54	$2.29	$6.60	$1.86	$3.20	($1.22)
Adjusted Weighted Average Basic Shares Outstanding	36.90M	36.60M	34.80M	34.20M	34.60M	33.60M	34.80M	39M	39.60M	39.20M	39.30M
Adjusted Diluted Earnings per Share	$2.84	$1.91	$1.37	($3.63)	($0.66)	$3.41	$2.08	$6.33	$1.83	$3.16	($1.22)
Adjusted Weighted Average Diluted Shares Outstanding	38.90M	37.90M	35.60M	34.20M	34.60M	34.80M	38.30M	40.70M	40.20M	39.70M	39.30M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	36.43M	34.81M	33.70M	35.36M	32.91M	34.23M	38.85M	39.63M	38.58M	39.58M	38.66M
Normalized Net Operating Profit after Tax (NOPAT)	99	86	66	-35	7.98	77	89	294	90	-53	-44
Normalized NOPAT Margin	5.80%	5.16%	3.82%	-2.14%	0.54%	5.79%	6.63%	16.92%	6.65%	-5.48%	-4.13%
Pre Tax Income Margin	9.41%	4.54%	3.57%	-5.02%	-1.41%	11.95%	8.97%	18.42%	9.30%	-12.99%	-10.57%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	42.68	16.31	10.90	-2.79	-0.30	7.73	4.93	9.29	2.78	-1.56	-2.03
NOPAT to Interest Expense	29.42	14.96	8.64	-1.95	-0.21	2.32	3.64	7.30	1.62	-1.09	-1.42
EBIT Less CapEx to Interest Expense	29.03	10.35	5.67	-4.32	-1.42	13.17	4.22	9.94	2.17	-2.07	-2.59
NOPAT Less CapEx to Interest Expense	15.76	9.00	3.40	-3.49	-1.33	7.76	2.94	7.95	1.01	-1.61	-1.98
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	65.40%	84.35%	10.86%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	175.27%	417.59%	191.19%	-75.42%	-517.47%	25.42%	0.00%	0.00%	249.32%	0.00%	-268.41%

This table displays calculated financial ratios and metrics derived from Synaptics' official financial filings.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024	3/29/2025	6/28/2025	9/27/2025	12/27/2025	3/28/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	38,729,741.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	38,729,741.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-0.21
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-46.95%	-32.88%	-27.34%	8.84%	8.41%	12.74%	12.35%	14.31%	13.50%	13.21%	10.35%
EBITDA Growth	-103.29%	-90.77%	-97.31%	-218.18%	172.34%	133.33%	54.55%	750.00%	473.53%	57.74%	78.15%
EBIT Growth	-133.94%	-145.43%	-185.66%	18.16%	19.32%	15.08%	-51.15%	22.19%	18.31%	0.66%	51.71%
NOPAT Growth	-135.32%	-148.68%	-193.14%	18.16%	19.32%	15.08%	-51.15%	22.19%	18.31%	0.66%	51.71%
Net Income Growth	-186.07%	-140.91%	-274.04%	990.17%	58.45%	120.00%	-20.44%	-102.26%	10.82%	-922.22%	63.30%
EPS Growth	-189.94%	-141.82%	-276.92%	1,026.32%	59.44%	121.74%	-21.74%	-102.46%	8.62%	-860.00%	62.50%
Operating Cash Flow Growth	-42.17%	-21.60%	-112.63%	-31.22%	-125.11%	-41.84%	635.77%	-12.00%	364.91%	30.70%	-70.30%
Free Cash Flow Firm Growth	105.06%	131.39%	-182.10%	-609.37%	-1,890.69%	-542.45%	-1,546.76%	22.23%	17.30%	34.81%	99.98%
Invested Capital Growth	-2.77%	-5.28%	1.05%	21.42%	16.98%	19.77%	30.37%	13.72%	12.01%	10.54%	-0.49%
Revenue Q/Q Growth	4.58%	-0.29%	0.13%	4.26%	4.16%	3.69%	-0.22%	6.08%	3.43%	3.42%	-2.74%
EBITDA Q/Q Growth	-313.64%	253.19%	63.64%	-244.44%	230.77%	394.12%	-29.17%	42.02%	15.38%	35.90%	-20.00%
EBIT Q/Q Growth	7.37%	49.15%	2.92%	-33.48%	8.68%	46.48%	-73.03%	7.98%	4.13%	34.91%	15.89%
NOPAT Q/Q Growth	7.37%	49.15%	2.79%	-78.74%	8.68%	46.48%	-73.03%	7.98%	4.13%	34.91%	15.89%
Net Income Q/Q Growth	-137.61%	83.81%	-101.11%	1,250.83%	-111.09%	107.79%	-1,311.11%	78.44%	-338.30%	28.16%	45.95%
EPS Q/Q Growth	-150.88%	83.92%	-100.00%	1,247.83%	-110.98%	108.62%	-1,220.00%	76.79%	-307.69%	28.30%	44.74%
Operating Cash Flow Q/Q Growth	-51.96%	-13.66%	-134.95%	574.45%	-117.54%	300.00%	221.93%	-22.07%	-47.20%	-1.32%	-26.85%
Free Cash Flow Firm Q/Q Growth	-76.10%	348.21%	-142.48%	-1,019.15%	15.96%	-10.74%	-58.11%	47.15%	10.63%	12.71%	99.95%
Invested Capital Q/Q Growth	5.31%	-0.68%	2.54%	13.21%	1.46%	1.70%	11.62%	-1.26%	-0.06%	0.35%	0.48%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	45.06%	45.99%	46.48%	45.84%	46.92%	45.73%	43.44%	42.96%	42.60%	43.54%	45.31%
EBITDA Margin	-1.98%	3.04%	0.76%	-1.05%	1.32%	6.29%	4.46%	5.98%	6.67%	8.76%	7.21%
Operating Margin	-14.81%	-7.55%	-7.33%	-12.57%	-11.02%	-5.69%	-9.87%	-8.56%	-7.93%	-4.99%	-4.32%
EBIT Margin	-14.81%	-7.55%	-9.82%	-12.57%	-11.02%	-5.69%	-9.87%	-8.56%	-7.93%	-4.99%	-4.32%
Profit (Net Income) Margin	-23.39%	-3.80%	-7.63%	84.20%	-8.96%	0.67%	-8.18%	-1.66%	-7.04%	-4.89%	-2.72%
Tax Burden Percent	136.95%	37.50%	77.68%	-567.57%	67.35%	-6.92%	79.56%	18.22%	90.75%	84.57%	52.63%
Interest Burden Percent	115.34%	134.08%	100.00%	118.01%	120.77%	171.05%	104.18%	106.61%	97.84%	115.89%	119.69%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-8.63%	-3.93%	-3.51%	-5.92%	-5.14%	-2.72%	-4.51%	-3.85%	-3.66%	-2.36%	-1.97%
ROIC Less NNEP Spread (ROIC-NNEP)	-36.75%	-1.07%	-9.74%	323.45%	-7.53%	4.15%	-5.73%	1.26%	-5.43%	-3.69%	-1.76%
Return on Net Nonoperating Assets (RNNOA)	-3.20%	-0.11%	-0.72%	16.67%	-0.76%	0.58%	-1.22%	0.21%	-0.93%	-0.85%	-0.54%
Return on Equity (ROE)	-11.83%	-4.03%	-4.23%	10.75%	-5.90%	-2.14%	-5.73%	-3.64%	-4.60%	-3.20%	-2.51%
Cash Return on Invested Capital (CROIC)	3.17%	2.55%	-6.58%	-24.34%	-20.16%	-22.35%	-30.81%	-16.78%	-15.04%	-13.67%	-2.44%
Operating Return on Assets (OROA)	-6.31%	-2.93%	-3.51%	-4.44%	-4.04%	-2.25%	-4.02%	-3.40%	-3.28%	-2.24%	-1.99%
Return on Assets (ROA)	-9.97%	-1.47%	-2.73%	29.72%	-3.29%	0.27%	-3.34%	-0.66%	-2.91%	-2.20%	-1.26%
Return on Common Equity (ROCE)	-11.83%	-4.03%	-4.23%	10.75%	-5.90%	-2.14%	-5.73%	-3.64%	-4.60%	-3.20%	-2.51%
Return on Equity Simple (ROE_SIMPLE)	-3.87%	-6.36%	-8.59%	0.00%	10.77%	12.27%	11.91%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-25	-13	-12	-22	-20	-11	-18	-17	-16	-11	-8.89
NOPAT Margin	-10.37%	-5.29%	-5.13%	-8.80%	-7.71%	-3.98%	-6.91%	-5.99%	-5.55%	-3.49%	-3.02%
Net Nonoperating Expense Percent (NNEP)	28.12%	-2.86%	6.23%	-329.38%	2.39%	-6.87%	1.22%	-5.12%	1.77%	1.33%	-0.21%
Return On Investment Capital (ROIC_SIMPLE)	-	-0.57%	-	-	-	-0.48%	-0.83%	-0.76%	-0.73%	-0.48%	-0.40%
Cost of Revenue to Revenue	54.94%	54.01%	53.52%	54.16%	53.09%	54.27%	56.56%	57.04%	57.40%	56.46%	54.69%
SG&A Expenses to Revenue	17.80%	16.75%	17.07%	15.68%	19.40%	18.53%	13.02%	16.30%	15.79%	15.80%	16.86%
R&D to Revenue	36.39%	34.60%	35.15%	34.11%	31.55%	31.18%	33.23%	33.10%	32.27%	31.44%	32.12%
Operating Expenses to Revenue	59.87%	53.54%	53.81%	58.41%	57.94%	51.42%	53.30%	51.52%	50.53%	48.53%	49.63%
Earnings before Interest and Taxes (EBIT)	-35	-18	-23	-31	-28	-15	-26	-24	-23	-15	-13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-4.70	7.20	1.80	-2.60	3.40	17	12	17	20	27	21
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.87	3.66	3.10	2.38	2.12	2.25	1.78	1.79	1.92	2.07	1.96
Price to Tangible Book Value (P/TBV)	34.79	33.50	22.99	9.62	8.02	9.85	11.31	9.59	10.39	10.38	9.61
Price to Revenue (P/Rev)	3.01	4.35	4.08	3.63	3.17	3.06	2.38	2.32	2.43	2.50	2.27
Price to Earnings (P/E)	0.00	0.00	0.00	27.74	19.65	18.32	14.96	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	3.61%	5.09%	5.46%	6.69%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.66	3.42	2.88	2.29	2.03	2.07	1.60	1.62	1.73	1.83	1.73
Enterprise Value to Revenue (EV/Rev)	3.15	4.47	4.24	3.73	3.29	3.30	2.78	2.68	2.76	2.85	2.64
Enterprise Value to EBITDA (EV/EBITDA)	23.06	58.42	320.93	471.01	205.40	131.63	97.76	58.76	47.09	43.62	36.78
Enterprise Value to EBIT (EV/EBIT)	507.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	724.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	12.07	15.99	24.06	26.34	40.77	53.11	19.25	20.28	16.70	17.12	22.25
Enterprise Value to Free Cash Flow (EV/FCFF)	82.68	130.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.81	0.80	0.79	0.66	0.66	0.61	0.60	0.60	0.60	0.60	0.62
Long-Term Debt to Equity	0.81	0.79	0.78	0.66	0.66	0.61	0.60	0.60	0.60	0.60	0.62
Financial Leverage	0.09	0.10	0.07	0.05	0.10	0.14	0.21	0.17	0.17	0.23	0.31
Leverage Ratio	2.12	2.10	2.06	2.01	2.00	1.96	1.94	1.89	1.87	1.84	1.85
Compound Leverage Factor	2.45	2.82	2.06	2.37	2.41	3.36	2.02	2.02	1.83	2.14	2.21
Debt to Total Capital	44.75%	44.41%	44.08%	39.88%	39.85%	37.69%	37.56%	37.44%	37.36%	37.66%	38.11%
Short-Term Debt to Total Capital	0.28%	0.27%	0.27%	0.25%	0.25%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	44.48%	44.13%	43.81%	39.63%	39.60%	37.69%	37.56%	37.44%	37.36%	37.66%	38.11%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	55.25%	55.59%	55.92%	60.12%	60.16%	62.31%	62.44%	62.56%	62.64%	62.34%	61.89%
Debt to EBITDA	6.25	12.39	78.52	128.01	61.90	32.91	28.28	17.04	12.83	11.18	9.95
Net Debt to EBITDA	0.97	1.60	11.70	12.63	7.54	9.34	13.99	7.80	5.77	5.33	5.14
Long-Term Debt to EBITDA	6.21	12.31	78.04	127.22	61.52	32.91	28.28	17.04	12.83	11.18	9.95
Debt to NOPAT	196.30	-24.47	-12.82	-13.68	-14.65	-12.91	-11.80	-12.67	-13.42	-13.45	-15.89
Net Debt to NOPAT	30.42	-3.16	-1.91	-1.35	-1.78	-3.67	-5.84	-5.80	-6.03	-6.41	-8.21
Long-Term Debt to NOPAT	195.09	-24.32	-12.74	-13.60	-14.56	-12.91	-11.80	-12.67	-13.42	-13.45	-15.89
Altman Z-Score	2.93	3.35	3.10	2.83	2.72	2.98	2.52	2.51	2.63	2.75	2.70
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.52	4.53	5.32	4.19	4.49	3.88	2.88	2.78	2.86	2.93	3.04
Quick Ratio	3.81	3.85	4.62	3.68	3.90	3.23	2.24	2.15	2.21	2.16	2.28
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	14	63	-27	-297	-250	-277	-438	-231	-207	-180	-0.09
Operating Cash Flow to CapEx	677.61%	376.92%	-152.22%	844.16%	-125.27%	485.11%	1,359.26%	866.67%	247.54%	256.90%	183.19%
Free Cash Flow to Firm to Interest Expense	2.59	10.26	0.00	0.00	-42.37	-25.63	-397.92	-8.12	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	8.41	6.43	0.00	0.00	-1.93	2.11	66.73	2.01	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	7.17	4.72	0.00	0.00	-3.47	1.68	61.82	1.78	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.43	0.39	0.36	0.35	0.37	0.40	0.41	0.40	0.41	0.45	0.46
Accounts Receivable Turnover	5.79	5.39	5.18	6.26	7.93	7.39	7.51	7.88	8.69	8.20	7.96
Inventory Turnover	3.71	3.56	3.91	4.14	4.18	4.44	4.59	4.69	4.76	4.69	4.49
Fixed Asset Turnover	17.50	15.03	13.14	13.52	13.33	13.80	14.33	14.56	14.14	14.45	15.27
Accounts Payable Turnover	6.11	6.51	7.77	7.80	7.14	6.50	7.04	6.39	7.11	7.24	7.88
Days Sales Outstanding (DSO)	63.02	67.71	70.51	58.27	46.03	49.37	48.61	46.33	42.01	44.52	45.86
Days Inventory Outstanding (DIO)	98.33	102.46	93.41	88.23	87.22	82.24	79.56	77.90	76.71	77.82	81.24
Days Payable Outstanding (DPO)	59.71	56.10	46.97	46.82	51.09	56.15	51.83	57.16	51.33	50.39	46.31
Cash Conversion Cycle (CCC)	101.65	114.06	116.95	99.68	82.16	75.46	76.34	67.07	67.38	71.95	80.79
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,356	1,346	1,381	1,563	1,586	1,613	1,800	1,777	1,776	1,782	1,791
Invested Capital Turnover	0.83	0.74	0.68	0.67	0.67	0.68	0.65	0.64	0.66	0.67	0.65
Increase / (Decrease) in Invested Capital	-39	-75	14	276	230	266	419	214	191	170	-8.80
Enterprise Value (EV)	3,602	4,598	3,980	3,580	3,225	3,330	2,884	2,879	3,066	3,263	3,093
Market Capitalization	3,451	4,472	3,834	3,484	3,106	3,094	2,471	2,497	2,690	2,864	2,661
Book Value per Share	$31.21	$31.13	$31.43	$37.14	$37.07	$34.35	$35.39	$36.19	$36.23	$35.49	$35.08
Tangible Book Value per Share	$2.57	$3.41	$4.24	$9.17	$9.78	$7.84	$5.57	$6.76	$6.69	$7.08	$7.15
Total Capital	2,180	2,195	2,209	2,440	2,439	2,209	2,221	2,230	2,236	2,220	2,195
Total Debt	976	975	974	973	972	833	834	835	835	836	837
Total Long-Term Debt	970	969	968	967	966	833	834	835	835	836	837
Net Debt	151	126	145	96	118	236	413	382	376	399	432
Capital Expenditures (CapEx)	6.70	10	9.00	7.70	9.10	4.70	5.40	6.60	12	12	12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	45	51	89	14	38	65	44	29	27	70	103
Debt-free Net Working Capital (DFNWC)	869	900	918	891	892	661	465	481	487	508	507
Net Working Capital (NWC)	863	894	912	885	886	661	465	481	487	508	507
Net Nonoperating Expense (NNE)	31	-3.53	5.92	-230	3.22	-12	3.39	-12	4.36	4.23	-0.89
Net Nonoperating Obligations (NNO)	151	126	145	96	118	236	413	382	376	399	432
Total Depreciation and Amortization (D&A)	31	25	25	29	32	32	38	41	43	42	34
Debt-free, Cash-free Net Working Capital to Revenue	3.91%	5.00%	9.48%	1.48%	3.92%	6.40%	4.21%	2.65%	2.44%	6.13%	8.77%
Debt-free Net Working Capital to Revenue	75.92%	87.51%	97.69%	92.88%	91.08%	65.44%	44.77%	44.77%	43.91%	44.36%	43.28%
Net Working Capital to Revenue	75.40%	86.92%	97.05%	92.26%	90.46%	65.44%	44.77%	44.77%	43.91%	44.36%	43.28%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.43)	($0.23)	($0.46)	$5.32	($0.58)	$0.05	($0.56)	($0.13)	($0.53)	($0.38)	($0.21)
Adjusted Weighted Average Basic Shares Outstanding	38.80M	39.20M	39.30M	39.20M	39.80M	39.70M	39M	39.30M	38.80M	38.90M	38.80M
Adjusted Diluted Earnings per Share	($1.43)	($0.23)	($0.46)	$5.28	($0.58)	$0.05	($0.56)	($0.13)	($0.53)	($0.38)	($0.21)
Adjusted Weighted Average Diluted Shares Outstanding	38.80M	39.20M	39.30M	39.70M	39.80M	39.80M	39M	39.30M	38.80M	38.90M	38.80M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	39.20M	39.30M	39.50M	39.58M	40.06M	39.19M	38.55M	38.66M	38.99M	38.73M	38.64M
Normalized Net Operating Profit after Tax (NOPAT)	-19	-12	-12	-21	-9.94	-10	-8.40	-16	-14	-11	-8.89
Normalized NOPAT Margin	-8.01%	-4.90%	-5.19%	-8.40%	-3.86%	-3.77%	-3.15%	-5.64%	-4.95%	-3.47%	-3.02%
Pre Tax Income Margin	-17.08%	-10.13%	-9.82%	-14.83%	-13.31%	-9.73%	-10.28%	-9.12%	-7.76%	-5.79%	-5.17%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-6.52	-2.93	0.00	0.00	-4.81	-1.41	-23.91	-0.85	0.00	0.00	0.00
NOPAT to Interest Expense	-4.56	-2.05	0.00	0.00	-3.37	-0.99	-16.74	-0.59	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-7.76	-4.64	0.00	0.00	-6.36	-1.84	-28.82	-1.08	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-5.80	-3.76	0.00	0.00	-4.91	-1.42	-21.65	-0.83	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-140.46%	-78.61%	0.00%	0.00%	44.11%	67.98%	-268.41%	-299.12%	-157.35%	-204.99%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways for Synaptics (SYNA) based on the quarterly cash flow, income statement, and balance sheet data provided for the last four years. The focus is on trends you can reasonably infer from the four-year view, with an emphasis on how they may impact investors.

Rising quarterly revenue into 2026. Revenue reached about $302.5 million in Q2 2026, up from $292.5 million in Q1 2026 and higher than the ~$283 million seen in Q4 2025, signaling improving top-line momentum into 2026.
Steady near-term operating cash flow. Net cash from continuing operating activities hovered around $30 million in early 2026 (Q1 2026: roughly $30.2M; Q2 2026: roughly $29.8M), suggesting the business is generating cash from core operations even as earnings swing.
Solid but leveraged balance sheet. By Q2 2026, total assets were about $2.57 billion, with total equity around $1.39 billion and long-term debt near $0.835–0.836 billion, indicating a solid equity base and relatively modest leverage.
Asset base and capitalization trending stable over four years. The company’s asset base and Equity position show resilience with only gradual year-over-year changes, helping support ongoing operations and capital needs.
Seasonality and one-off effects can mask underlying trends. Revenue exhibits seasonal patterns (e.g., Q4 historically stronger) and earnings can be affected by non-operating items (e.g., a large one-time net income spike in Q4 2024), so quarterly results should be interpreted within a longer context.
Non-cash adjustments are sizable and important to note. Depreciation and amortization are large (for example, Amortization around $34M in Q2 2026 and Depreciation around $7.6M), which boosts cash flow from operations in some periods but depresses reported net income.
Recent profitability has been mixed/negative. Net income from continuing operations was negative in several recent quarters (e.g., Q2 2026: -$14.8M; Q1 2026: -$20.6M; Q3 2025: -$21.8M), signaling ongoing profitability challenges despite revenue momentum.
Operating expenses remain a drag on margins. Total operating expenses in some quarters are large (e.g., Q2 2026 around $146.8M) with ongoing investment in SG&A and R&D, which weighs on quarterly earnings despite revenue stability.
Debt and interest costs contribute to cash outlays over time. Long-term debt has remained substantial (roughly $0.83–0.97B across periods) and interest expenses appear in multiple quarters, adding pressure to free cash flow and net income.

05/21/26 04:37 PM ETAI Generated. May Contain Errors.

Synaptics Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Synaptics' financial year ends in June. Their financial year 2025 ended on June 28, 2025.

Synaptics' net income appears to be on an upward trend, with a most recent value of -$47.80 million in 2025, falling from $110.40 million in 2015. The previous period was $125.60 million in 2024. Find out what analysts predict for Synaptics in the coming months.

Synaptics' total operating income in 2025 was -$94.10 million, based on the following breakdown:

Total Gross Profit: $480.40 million
Total Operating Expenses: $574.50 million

Over the last 10 years, Synaptics' total revenue changed from $1.70 billion in 2015 to $1.07 billion in 2025, a change of -36.9%.

Synaptics' total liabilities were at $1.19 billion at the end of 2025, a 12.4% decrease from 2024, and a 63.8% increase since 2015.

In the past 10 years, Synaptics' cash and equivalents has ranged from $301 million in 2018 to $924.70 million in 2023, and is currently $391.50 million as of their latest financial filing in 2025.

Over the last 10 years, Synaptics' book value per share changed from 21.53 in 2015 to 36.19 in 2025, a change of 68.1%.

Related Companies

Financial statements for NASDAQ:SYNA last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synaptics (SYNA) Financials

Financials Breakdown Chart

Key Financial Trends

Synaptics Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Synaptics (SYNA) Financials

Annual Income Statements for Synaptics

Quarterly Income Statements for Synaptics

Annual Cash Flow Statements for Synaptics

Quarterly Cash Flow Statements for Synaptics

Annual Balance Sheets for Synaptics

Quarterly Balance Sheets for Synaptics

Annual Metrics And Ratios for Synaptics

Quarterly Metrics And Ratios for Synaptics

Financials Breakdown Chart

Key Financial Trends

Synaptics Financials - Frequently Asked Questions

When does Synaptics' fiscal year end?

How has Synaptics' net income changed over the last 10 years?

What is Synaptics' operating income?

How has Synaptics' revenue changed over the last 10 years?

How much debt does Synaptics have?

How much cash does Synaptics have?

How has Synaptics' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools